Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 6382 | 2.18 |
09:34 ET | 23992 | 2.18 |
09:36 ET | 12598 | 2.185 |
09:38 ET | 2600 | 2.19 |
09:39 ET | 300 | 2.19 |
09:41 ET | 1157 | 2.2 |
09:43 ET | 2379 | 2.2056 |
09:45 ET | 10406 | 2.21 |
09:48 ET | 8174 | 2.22 |
09:50 ET | 1590 | 2.21 |
09:52 ET | 12392 | 2.23 |
09:54 ET | 200 | 2.225 |
09:56 ET | 200 | 2.23 |
09:57 ET | 5193 | 2.215 |
09:59 ET | 100 | 2.215 |
10:01 ET | 100 | 2.22 |
10:03 ET | 11662 | 2.2201 |
10:06 ET | 3080 | 2.2271 |
10:08 ET | 1160 | 2.23 |
10:10 ET | 882 | 2.24 |
10:12 ET | 29363 | 2.245 |
10:14 ET | 6975 | 2.245 |
10:15 ET | 6526 | 2.25 |
10:17 ET | 28951 | 2.28 |
10:19 ET | 30547 | 2.31 |
10:21 ET | 800 | 2.305 |
10:24 ET | 23334 | 2.305 |
10:26 ET | 8606 | 2.3 |
10:28 ET | 4500 | 2.305 |
10:30 ET | 600 | 2.305 |
10:32 ET | 648 | 2.305 |
10:33 ET | 635 | 2.306 |
10:35 ET | 2005 | 2.32 |
10:37 ET | 50272 | 2.31 |
10:39 ET | 200 | 2.305 |
10:42 ET | 1699 | 2.3 |
10:44 ET | 6079 | 2.2943 |
10:46 ET | 1700 | 2.295 |
10:48 ET | 700 | 2.3 |
10:50 ET | 100 | 2.3 |
10:51 ET | 5583 | 2.31 |
10:53 ET | 100 | 2.305 |
10:55 ET | 8881 | 2.305 |
10:57 ET | 1000 | 2.305 |
11:00 ET | 1354 | 2.3 |
11:02 ET | 3224 | 2.305 |
11:04 ET | 484 | 2.305 |
11:06 ET | 1115 | 2.305 |
11:08 ET | 100 | 2.31 |
11:09 ET | 172 | 2.305 |
11:11 ET | 5800 | 2.305 |
11:13 ET | 5890 | 2.3 |
11:15 ET | 2616 | 2.305 |
11:18 ET | 300 | 2.305 |
11:20 ET | 4920 | 2.315 |
11:22 ET | 1900 | 2.3 |
11:26 ET | 1660 | 2.3 |
11:29 ET | 200 | 2.31 |
11:31 ET | 674 | 2.305 |
11:33 ET | 900 | 2.305 |
11:36 ET | 967 | 2.3 |
11:38 ET | 7084 | 2.315 |
11:40 ET | 970 | 2.315 |
11:42 ET | 344 | 2.3152 |
11:44 ET | 269 | 2.315 |
11:47 ET | 4064 | 2.32 |
11:49 ET | 629 | 2.32 |
11:51 ET | 5380 | 2.335 |
11:54 ET | 42218 | 2.35 |
11:56 ET | 1500 | 2.348 |
11:58 ET | 1522 | 2.355 |
12:00 ET | 2270 | 2.35 |
12:02 ET | 829 | 2.36 |
12:03 ET | 452 | 2.355 |
12:05 ET | 3465 | 2.345 |
12:07 ET | 350 | 2.346 |
12:09 ET | 17415 | 2.35 |
12:14 ET | 300 | 2.36 |
12:16 ET | 400 | 2.355 |
12:18 ET | 305 | 2.35 |
12:20 ET | 13505 | 2.375 |
12:21 ET | 5169 | 2.38 |
12:23 ET | 6821 | 2.385 |
12:25 ET | 1939 | 2.3897 |
12:27 ET | 4382 | 2.3809 |
12:30 ET | 10328 | 2.4 |
12:32 ET | 1498 | 2.4 |
12:34 ET | 800 | 2.4 |
12:36 ET | 389 | 2.395 |
12:38 ET | 22731 | 2.395 |
12:39 ET | 2074 | 2.41 |
12:41 ET | 10269 | 2.405 |
12:43 ET | 25163 | 2.375 |
12:45 ET | 28513 | 2.4 |
12:48 ET | 1300 | 2.395 |
12:50 ET | 2571 | 2.385 |
12:52 ET | 4771 | 2.39 |
12:54 ET | 886 | 2.39 |
12:56 ET | 8531 | 2.385 |
12:57 ET | 3619 | 2.41 |
12:59 ET | 3643 | 2.395 |
01:01 ET | 669 | 2.3911 |
01:03 ET | 100 | 2.395 |
01:06 ET | 7297 | 2.365 |
01:08 ET | 6110 | 2.365 |
01:10 ET | 2810 | 2.3646 |
01:12 ET | 3328 | 2.3572 |
01:14 ET | 1255 | 2.36 |
01:15 ET | 1442 | 2.355 |
01:17 ET | 743 | 2.355 |
01:19 ET | 2210 | 2.35 |
01:21 ET | 1100 | 2.355 |
01:24 ET | 1979 | 2.355 |
01:26 ET | 1000 | 2.355 |
01:28 ET | 6224 | 2.34 |
01:30 ET | 3292 | 2.34 |
01:32 ET | 4226 | 2.335 |
01:33 ET | 1100 | 2.335 |
01:35 ET | 1041 | 2.33 |
01:37 ET | 3511 | 2.325 |
01:39 ET | 256 | 2.325 |
01:42 ET | 842 | 2.325 |
01:44 ET | 414 | 2.325 |
01:46 ET | 1975 | 2.325 |
01:48 ET | 1462 | 2.325 |
01:50 ET | 144 | 2.325 |
01:51 ET | 707 | 2.33 |
01:53 ET | 1254 | 2.33 |
01:55 ET | 1381 | 2.325 |
01:57 ET | 22406 | 2.335 |
02:00 ET | 5260 | 2.335 |
02:02 ET | 155 | 2.335 |
02:04 ET | 2145 | 2.33 |
02:06 ET | 655 | 2.325 |
02:08 ET | 1462 | 2.325 |
02:11 ET | 6634 | 2.345 |
02:13 ET | 200 | 2.345 |
02:15 ET | 548 | 2.345 |
02:18 ET | 29524 | 2.355 |
02:20 ET | 5153 | 2.365 |
02:22 ET | 6409 | 2.3613 |
02:24 ET | 7652 | 2.365 |
02:27 ET | 4355 | 2.375 |
02:29 ET | 4014 | 2.375 |
02:31 ET | 1200 | 2.375 |
02:33 ET | 7748 | 2.365 |
02:36 ET | 7192 | 2.38 |
02:38 ET | 300 | 2.375 |
02:40 ET | 13192 | 2.375 |
02:42 ET | 2421 | 2.375 |
02:44 ET | 968 | 2.375 |
02:45 ET | 700 | 2.3757 |
02:47 ET | 512 | 2.375 |
02:49 ET | 268 | 2.3749 |
02:51 ET | 16186 | 2.395 |
02:54 ET | 9994 | 2.395 |
02:56 ET | 7700 | 2.395 |
02:58 ET | 37475 | 2.375 |
03:00 ET | 1911 | 2.375 |
03:02 ET | 32318 | 2.3501 |
03:03 ET | 2095 | 2.345 |
03:05 ET | 300 | 2.345 |
03:07 ET | 600 | 2.345 |
03:09 ET | 3494 | 2.335 |
03:12 ET | 9829 | 2.36 |
03:14 ET | 100 | 2.36 |
03:16 ET | 348 | 2.355 |
03:21 ET | 2102 | 2.35 |
03:25 ET | 372 | 2.345 |
03:27 ET | 3538 | 2.345 |
03:30 ET | 392 | 2.345 |
03:32 ET | 653 | 2.345 |
03:34 ET | 5900 | 2.345 |
03:36 ET | 4760 | 2.345 |
03:38 ET | 100 | 2.345 |
03:39 ET | 612 | 2.345 |
03:41 ET | 3959 | 2.345 |
03:43 ET | 1700 | 2.35 |
03:45 ET | 2444 | 2.35 |
03:48 ET | 852 | 2.345 |
03:50 ET | 7093 | 2.35 |
03:52 ET | 3177 | 2.345 |
03:54 ET | 5380 | 2.345 |
03:56 ET | 32019 | 2.37 |
03:57 ET | 21975 | 2.365 |
03:59 ET | 280350 | 2.34 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 739.9M | -1.1x | --- |
MBX Biosciences Inc | 750.5M | -16.5x | --- |
Erasca Inc | 711.9M | -2.7x | --- |
89Bio Inc | 768.9M | -3.6x | --- |
Terns Pharmaceuticals Inc | 692.1M | -6.2x | --- |
Oric Pharmaceuticals Inc | 690.6M | -5.4x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $739.9M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 334.8M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.36 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 515.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.